Across TCGA pan-cancer cohorts, KRT125P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of KRT125P’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where KRT125P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KRT125P is over-expressed in tumor.
STAD are the cancer types where KRT125P tumor–normal differential expression is most reproducible.